Mitsubishi UFJ Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $247K | Buy |
1,795
+303
| +20% | +$41.7K | ﹤0.01% | 952 |
|
2025
Q1 | $269K | Buy |
1,492
+125
| +9% | +$22.5K | ﹤0.01% | 918 |
|
2024
Q4 | $216K | Sell |
1,367
-210
| -13% | -$33.2K | ﹤0.01% | 978 |
|
2024
Q3 | $287K | Sell |
1,577
-149
| -9% | -$27.1K | ﹤0.01% | 920 |
|
2024
Q2 | $317K | Sell |
1,726
-517
| -23% | -$94.9K | ﹤0.01% | 911 |
|
2024
Q1 | $399K | Sell |
2,243
-102
| -4% | -$18.1K | ﹤0.01% | 897 |
|
2023
Q4 | $279K | Sell |
2,345
-662
| -22% | -$78.7K | ﹤0.01% | 977 |
|
2023
Q3 | $349K | Buy |
3,007
+283
| +10% | +$32.8K | ﹤0.01% | 968 |
|
2023
Q2 | $320K | Sell |
2,724
-752
| -22% | -$88.3K | ﹤0.01% | 982 |
|
2023
Q1 | $278K | Buy |
3,476
+227
| +7% | +$18.2K | ﹤0.01% | 986 |
|
2022
Q4 | $257K | Sell |
3,249
-1,179
| -27% | -$93.4K | ﹤0.01% | 998 |
|
2022
Q3 | $309K | Buy |
4,428
+72
| +2% | +$5.02K | ﹤0.01% | 972 |
|
2022
Q2 | $286K | Sell |
4,356
-1,845
| -30% | -$121K | ﹤0.01% | 999 |
|
2022
Q1 | $413K | Buy |
6,201
+285
| +5% | +$19K | ﹤0.01% | 969 |
|
2021
Q4 | $427K | Buy |
5,916
+1,186
| +25% | +$85.6K | ﹤0.01% | 972 |
|
2021
Q3 | $247K | Buy |
4,730
+129
| +3% | +$6.74K | ﹤0.01% | 1031 |
|
2021
Q2 | $313K | Sell |
4,601
-3,971
| -46% | -$270K | ﹤0.01% | 1033 |
|
2021
Q1 | $660K | Buy |
8,572
+2,764
| +48% | +$213K | ﹤0.01% | 846 |
|
2020
Q4 | $348K | Buy |
5,808
+2,222
| +62% | +$133K | ﹤0.01% | 872 |
|
2020
Q3 | $154K | Buy |
3,586
+11
| +0.3% | +$472 | ﹤0.01% | 924 |
|
2020
Q2 | $148K | Buy |
3,575
+241
| +7% | +$9.98K | ﹤0.01% | 923 |
|
2020
Q1 | $144K | Buy |
3,334
+695
| +26% | +$30K | ﹤0.01% | 892 |
|
2019
Q4 | $157K | Buy |
+2,639
| New | +$157K | ﹤0.01% | 910 |
|